8-KRegulation FDExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Regulation FD Disclosure (Jan 9, 2009)

Filed January 9, 2009For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on January 9, 2009, to disclose information that will be presented at the J.P. Morgan 27th Annual Healthcare Conference. The filing primarily consists of slides prepared for investor meetings scheduled between January 12-15, 2009. Investors attending the conference or seeking an update on the company's progress should review these slides for the latest information. While the 8-K itself does not contain detailed financial statements or specific business updates beyond the announcement of presentation materials, the attached slides are intended to cover key aspects of Regeneron's business, pipeline, and strategic outlook. Investors are advised to access and analyze these slides to gain insights into the company's development programs and future prospects as presented to potential investors and analysts.

Key Highlights

  • 1Regeneron Pharmaceuticals filed an 8-K on January 9, 2009.
  • 2The filing's primary purpose is to disclose materials for the J.P. Morgan 27th Annual Healthcare Conference.
  • 3Presentation slides intended for investor meetings are attached as Exhibit 99(a).
  • 4The conference is scheduled to take place from January 12-15, 2009.
  • 5The 8-K itself does not contain new financial data or operational details, but directs investors to the presentation materials for updates.
  • 6Investors interested in Regeneron's current standing should seek out the slides referenced in the filing.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose the presentation slides that Regeneron Pharmaceuticals, Inc. intends to use when meeting with investors at the J.P. Morgan 27th Annual Healthcare Conference.

This 8-K filing does not contain detailed financial statements or specific business updates directly within the report. The key information is contained in the attached slides (Exhibit 99(a)), which were prepared for investor presentations at the J.P. Morgan Healthcare Conference. Investors should refer to these slides for the most current information.

The investor meetings at which these slides will be used are scheduled to take place at the J.P. Morgan 27th Annual Healthcare Conference in San Francisco, from January 12-15, 2009.

No, this specific 8-K filing does not contain new financial results or forward-looking guidance. It serves as a disclosure mechanism for presentation materials being used in upcoming investor conferences.